SCHEMBL601589

SCHEMBL601589

C1CCC(C2COCCOCCOCCO2)CC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11211959 1.00 ALDH1A1 (0.30) ALDH1A1
SCHEMBL11797167 1.00 ALDH1A1 (0.30) ALDH1A1
SCHEMBL2177632 1.00 ALDH1A1 (0.30) ALDH1A1
SCHEMBL1777453 1.00 ALDH1A1 (0.30) ALDH1A1
SCHEMBL7741521 0.98 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7737983 0.98 ALDH1A1 (0.32) ALDH1A1
SCHEMBL60853 0.98 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7739260 0.98 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7739529 0.98 ALDH1A1 (0.32) ALDH1A1
SCHEMBL6636153 0.95 ALDH1A1 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023099777-A1 METHOD OF UNDERWATER BONDING Henkel IP & Holding GmbH (DE) 2023-06-08 WO claimed
EP-3837328-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2021-06-23 EP claimed
EP-3700991-A1 TOUGHENED, LOW ODOR/LOW BLOOM CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2020-09-02 EP claimed
EP-3700951-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2020-09-02 EP claimed
WO-2020035579-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2020-02-20 WO claimed
EP-3371269-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2018-09-12 EP claimed
EP-3371268-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2018-09-12 EP claimed
WO-2017077091-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2017-05-11 WO claimed
WO-2017077089-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2017-05-11 WO claimed
EP-2999689-A1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2016-03-30 EP claimed
EP-2970719-A2 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2016-01-20 EP claimed
WO-2014189938-A1 CYANOACRYLATE COMPOSITIONS Henkel US IP LLC (US) 2014-11-27 WO claimed
WO-2014140798-A2 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2014-09-18 WO claimed
WO-2013112315-A1 CYANOACRYLATE COMPOSITIONS HENKEL CORPORATION (US) 2013-08-01 WO claimed
WO-2023099777-A1 METHOD OF UNDERWATER BONDING Henkel IP & Holding GmbH (DE) 2023-06-08 WO disclosed
EP-4133020-A1 LOW ODOUR CYANOACRYLATE COMPOSITION Henkel AG & Co. KGaA (DE) 2023-02-15 EP disclosed
EP-3941989-A1 CYANOACRYLATE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2022-01-26 EP disclosed
US-20120039838-A1 WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN ADHEZION BIOMEDICAL, LLC (US) 2012-02-16 US disclosed
EP-2092017-A1 CYANOACRYLATE COMPOSITIONS CONTAINING DISPERSIONS OF CORE SHELL RUBBERS IN (METH)ACRYLATES Henkel Corporation (US) 2009-08-26 EP disclosed
WO-2008085285-A1 CYANOACRYLATE COMPOSITIONS CONTAINING DISPERSIONS OF CORE SHELL RUBBERS IN (METH)ACRYLATES HENKEL CORPORATION (US) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120039838-A1 WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN COL14A1, PLOD2, PLOD1 ALDH1A1 574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.